Clifford Hsieh, MD
Dermatology · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hsieh’s office at (408) 848-7040 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A169244 · Current
Licensed to practise in California · since 2020 · expires 2028-07-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 125068785Temporary Medical Permit · since 2019 · expires 2020-06-30Specialty on the licence: DermatologyExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$0 in 2022
Medicaid paid $0 for 12 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $0 |
| 2022 | 12 | 1 | 12 | $0 |
Drugs they prescribed that Part D paid
$315,439
Pharmacies billed $315,439 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 762) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
657 generic and 105 brand-name prescriptions · $315,439 in drug cost · 23 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Sensoready (2 Pens) | 12 | $72,745 | $6,062 |
| Adbry | 16 | $56,306 | $3,519 |
| Opzelura | 16 | $34,281 | $2,143 |
| Amjevita(Cf) | 16 | $14,807 | $925 |
| Tacrolimus | 60 | $6,537 | $109 |
See all 18 drugs
| Cosentyx Sensoready (2 Pens) | 12 | $72,745 | $6,062 |
| Adbry | 16 | $56,306 | $3,519 |
| Opzelura | 16 | $34,281 | $2,143 |
| Amjevita(Cf) | 16 | $14,807 | $925 |
| Tacrolimus | 60 | $6,537 | $109 |
| Fluorouracil | 82 | $3,077 | $38 |
| Ivermectin | 20 | $2,777 | $139 |
| Clobetasol Propionate | 66 | $1,813 | $27 |
| Triamcinolone Acetonide | 55 | $1,763 | $32 |
| Ketoconazole | 93 | $1,566 | $17 |
| Calcipotriene | 13 | $1,510 | $116 |
| Fluocinonide | 62 | $1,379 | $22 |
| Betamethasone Diprop Augmented | 22 | $995 | $45 |
| Clindamycin Phosphate | 32 | $689 | $22 |
| Doxycycline Monohydrate | 14 | $562 | $40 |
| Desonide | 17 | $305 | $18 |
| Hydrocortisone | 13 | $173 | $13 |
| Mupirocin | 16 | $170 | $11 |
Year by year
| 2024 | 762 | 266 | 0% (0) | 14% | $315,439 |
| 2023 | 858 | 291 | 0% (0) | 11% | $281,944 |
| 2022 | 681 | 245 | 0% (0) | 10% | $150,937 |
| 2021 | 515 | 228 | 0% (0) | 10% | $92,070 |
| 2020 | 243 | 115 | 0% (0) | 18% | $23,118 |
| 2019 | 372 | 131 | None | 18% | $27,193 |
| 2018 | 297 | 109 | None | 13% | $21,131 |
| 2017 | 171 | 72 | None | None | $20,703 |
| 2016 | 18 | 11 | 0% (0) | 0% | $2,095 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Otezla | 13 | $63,527 | $4,887 |
| Dupixent | 15 | $52,184 | $3,479 |
| Vectical | 25 | $4,708 | $188 |
| Tacrolimus | 47 | $4,130 | $88 |
| Fluorouracil | 86 | $3,331 | $39 |
| Fluocinonide | 77 | $3,189 | $41 |
| Ivermectin | 15 | $2,887 | $192 |
| Clobetasol Propionate | 88 | $2,059 | $23 |
| Ketoconazole | 103 | $2,026 | $20 |
| Triamcinolone Acetonide | 59 | $1,901 | $32 |
| Betamethasone Diprop Augmented | 41 | $1,854 | $45 |
| Desoximetasone | 19 | $874 | $46 |
| Doxycycline Monohydrate | 14 | $652 | $47 |
| Desonide | 15 | $370 | $25 |
| Clindamycin Phosphate | 16 | $338 | $21 |
| Metronidazole | 16 | $322 | $20 |
| Mupirocin | 26 | $301 | $12 |
| Hydrocortisone | 14 | $176 | $13 |
2022: 16 drugs
| Enbrel Sureclick | 12 | $61,635 | $5,136 |
| Fluorouracil | 74 | $4,166 | $56 |
| Tacrolimus | 33 | $3,771 | $114 |
| Vectical | 25 | $3,762 | $150 |
| Clobetasol Propionate | 80 | $3,505 | $44 |
| Fluocinonide | 68 | $3,374 | $50 |
| Betamethasone Diprop Augmented | 44 | $2,876 | $65 |
| Calcipotriene | 16 | $2,198 | $137 |
| Triamcinolone Acetonide | 60 | $1,789 | $30 |
| Ketoconazole | 74 | $1,443 | $20 |
| Alclometasone Dipropionate | 17 | $633 | $37 |
| Metronidazole | 13 | $480 | $37 |
| Doxycycline Monohydrate | 13 | $434 | $33 |
| Clindamycin Phosphate | 16 | $359 | $22 |
| Hydrocortisone | 11 | $149 | $14 |
| Mupirocin | 11 | $142 | $13 |
2021: 14 drugs
| Otezla | 18 | $62,808 | $3,489 |
| Fluorouracil | 73 | $4,485 | $61 |
| Clobetasol Propionate | 55 | $3,970 | $72 |
| Fluocinonide | 58 | $2,825 | $49 |
| Tacrolimus | 19 | $1,992 | $105 |
| Betamethasone Diprop Augmented | 25 | $1,577 | $63 |
| Triamcinolone Acetonide | 45 | $1,361 | $30 |
| Ketoconazole | 55 | $1,118 | $20 |
| Metronidazole | 11 | $632 | $57 |
| Doxycycline Hyclate | 12 | $624 | $52 |
| Hydrocortisone | 24 | $405 | $17 |
| Clindamycin Phosphate | 15 | $330 | $22 |
| Doxycycline Monohydrate | 11 | $288 | $26 |
| Mupirocin | 17 | $219 | $13 |
2020: 7 drugs
| Clobetasol Propionate | 17 | $2,721 | $160 |
| Fluocinonide | 21 | $2,096 | $100 |
| Fluorouracil | 23 | $1,799 | $78 |
| Clindamycin Phosphate | 17 | $1,355 | $80 |
| Econazole Nitrate | 14 | $999 | $71 |
| Ketoconazole | 31 | $769 | $25 |
| Triamcinolone Acetonide | 26 | $700 | $27 |
2019: 7 drugs
| Fluocinonide | 35 | $4,108 | $117 |
| Clindamycin Phosphate | 43 | $3,296 | $77 |
| Ketoconazole | 65 | $2,251 | $35 |
| Econazole Nitrate | 31 | $2,081 | $67 |
| Doxycycline Hyclate | 20 | $1,248 | $62 |
| Triamcinolone Acetonide | 35 | $618 | $18 |
| Mupirocin | 22 | $240 | $11 |
2018: 9 drugs
| Ketoconazole | 62 | $2,294 | $37 |
| Econazole Nitrate | 25 | $1,796 | $72 |
| Clindamycin Phosphate | 12 | $936 | $78 |
| Doxycycline Hyclate | 17 | $720 | $42 |
| Triamcinolone Acetonide | 25 | $554 | $22 |
| Hydroxyzine | 12 | $364 | $30 |
| Ammonium Lactate | 11 | $294 | $27 |
| Hydrocortisone | 11 | $265 | $24 |
| Mupirocin | 15 | $156 | $10 |
2017: 2 drugs
| Econazole Nitrate | 18 | $1,719 | $96 |
| Ketoconazole | 18 | $372 | $21 |
Money from drug and device companies
$205 in 2023
| 2023 | 2 | 2 | None | $205 |
| 2022 | 1 | 1 | None | $21 |
| 2021 | 1 | 1 | None | $28 |
| 2020 | 4 | 4 | None | $311 |
| 2019 | 14 | 30 | None | $3,076 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | None | $132 | 1 payment
|
| Pfizer | Cibinqo | $73 | 1 payment
|
See all 2 published payments
| Arcutis Biotherapeutics | Meals · 2023-12-12 | None | $132 |
| Pfizer | Meals · 2023-10-06 | Cibinqo | $73 |
See earlier years (2022, 2021, 2020, 2019)
2022: $21
| Galderma Laboratories L.P. | None | $21 | 1 payment
|
2021: $28
| AbbVie | Humira | $28 | 1 payment
|
2020: $311
| AbbVie | Humira | $101 | 1 payment
|
| Pfizer | Eucrisa | $97 | 1 payment
|
| Amgen | Otezla | $96 | 1 payment
|
| Sun Pharmaceutical Industries | Odomzo | $17 | 1 payment
|
2019: $3,076
| AbbVie | Humira | $798 | 7 payments
|
| Novartis Pharmaceuticals | Cosentyx | $395 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $367 | 4 payments
|
| Celgene | Otezla | $262 | 2 payments
|
| Galderma Laboratories L.P. | Oracea | $236 | 2 payments
|
| Genzyme | Dupixent | $219 | 2 payments
|
| Pfizer | Eucrisa | $126 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $120 | 1 payment
|
| Kyowa Kirin | Poteligeo | $119 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $115 | 1 payment
|
| Dermira | Qbrexza | $112 | 1 payment
|
| Allergan | None | $97 | 1 payment
|
| Lilly USA | Taltz | $86 | 2 payments
|
| Janssen Biotech | Tremfya | $22 | 1 payment
|
Professional record
- NPI
- 1164876801
- Licence
- CA A169244, IL 125.068785California A169244: Current · expires 2028-07-31Illinois 125068785: Expired
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 7520 Arroyo Cir, Gilroy, CA, 95020
- NPI first listed
- 2016-04-19
- NPI last updated
- 2021-12-20
- NPI record certified
- 2020-10-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5841 S Maryland Ave # Mc5067, Chicago, IL, 60637
This office lists an electronic records connection.